Dr. Kane on Challenges Facing Genetic Testing in Prostate Cancer

Christopher J. Kane, MD
Published: Wednesday, Jul 19, 2017



Christopher J. Kane, MD, professor of Surgery, chair, Department of Urology, UC San Diego Health, discusses challenges facing genetic testing for patients with prostate cancer.

According to Kane, the technology often outstrips the ethics and the clinical precision data. We have multiple ways to obtain various genetic data, but physicians are still unsure of the next steps following that information.

It is still quite early in the genetic testing space, so more studies are required to develop new data, states Kane.
 


Christopher J. Kane, MD, professor of Surgery, chair, Department of Urology, UC San Diego Health, discusses challenges facing genetic testing for patients with prostate cancer.

According to Kane, the technology often outstrips the ethics and the clinical precision data. We have multiple ways to obtain various genetic data, but physicians are still unsure of the next steps following that information.

It is still quite early in the genetic testing space, so more studies are required to develop new data, states Kane.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x